Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

IM Cannabis (IMCC) EBITDA Margin: 2019-2025

Historic EBITDA Margin for IM Cannabis (IMCC) over the last 6 years, with Sep 2025 value amounting to -34.84%.

  • IM Cannabis' EBITDA Margin fell 2393.00% to -34.84% in Q3 2025 from the same period last year, while for Sep 2025 it was -19.68%, marking a year-over-year decrease of 576.00%. This contributed to the annual value of -24.44% for FY2024, which is 220.00% down from last year.
  • IM Cannabis' EBITDA Margin amounted to -34.84% in Q3 2025, which was down 201.13% from -11.57% recorded in Q2 2025.
  • Over the past 5 years, IM Cannabis' EBITDA Margin peaked at 155.73% during Q2 2022, and registered a low of -899.17% during Q3 2022.
  • In the last 3 years, IM Cannabis' EBITDA Margin had a median value of -15.68% in 2023 and averaged -17.04%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first tumbled by 84,022bps in 2022, then skyrocketed by 88,349bps in 2023.
  • Over the past 5 years, IM Cannabis' EBITDA Margin (Quarterly) stood at -277.91% in 2021, then tumbled by 7,388bps to -351.79% in 2022, then spiked by 31,269bps to -39.10% in 2023, then surged by 1,081bps to -28.29% in 2024, then slumped by 2,393bps to -34.84% in 2025.
  • Its EBITDA Margin was -34.84% in Q3 2025, compared to -11.57% in Q2 2025 and -1.25% in Q1 2025.